Nexteligent Holdings Inc (NXGT)

[jump1]

NEW YORK, January 18, 2023, Nexteligent Holdings, Inc. (OTC:NXGT)— Nexteligent has increased its authorized shares of common stock, par value $.001 per share, to 125,000,000, and the authorized blank check preferred, par value $.001 per share, have been increased to 52,301,000

[FIREMEDIC0001]

Beautiful...just need some good news and she is gone

[2times2]

Authorized Shares 100,000,000 01/10/2023
Outstanding Shares 73,937,469 01/10/2023
Restricted 36,406,813 01/10/2023
Unrestricted 37,530,656 01/10/2023

[FIREMEDIC0001]

Maybe they will get their act together in 2023...I'll be loading some 00s in hopes of a pump or legitimate news...still can fly with this tiny SS

[WHITTENHALLJR]

Been a real disappointment… still have a few shares

[EmptyBones]

Looks like this is going to 00's soon.. This company has no clue what they are doing imo... Traders stacking the ask trying to save there lives

[WHITTENHALLJR]

Yup

[EmptyBones]

Looks like NXGT is done.. Go get kegs

[WHITTENHALLJR]

Bi_ei is going to help me find a huge position in kegs

[BIOCHEMUP]

Thomas Papini will support Nexteligent’s growth initiatives, including up listing to the OTCQX, which requires the formation of an independent audit committee. Additionally, Mr. Papini will support Nexteligent’s future acquisition process following its planned acquisition of IMS Experts, a national provider of Durable Medical Equipment that will join Nexteligent’s existing Revenue Cycle Management operations.

So according to the last PR from a few weeks ago the IMS acquisition is still to be completed.

I’d like to hear from management what they are outlining for corporate strategy in 2023.

[EmptyBones]

panic lol hell ya

[Gandoshka666]

Mr. EmptyDeep pockets lol are you in panic mode?

[EmptyBones]

Looks like this is going in 00's soon. I will wait to buy .007

[FIREMEDIC0001]

We all know this is super thin so any surprise news from the company could be a 10 bagger at these levels

[FIREMEDIC0001]

Soon as the company went silent I had a hunch...hoping this drops to trips so we can average down and get out when there some kind of pump...expecting people to sell here to take their losses for taxes soon

[EmptyBones]

If you knew that you should have let people know (:

[FIREMEDIC0001]

Thought we were in trouble 6 months ago

[EmptyBones]

.014 now this company is in trouble imo

[BIOCHEMUP]

When is the next financial?

[seven77]

Nice news but zero volume. Hopefully tomorrow it moves a little. Shares are tightly held and only 2 million shares added to the o/s since march. I'm thinking we are all expecting a big move soon.

[EmptyBones]

Appreciate that... I didn't even see it.. My guess they are getting ready to move this... That is a big deal

[BIOCHEMUP]

Thanks for notifying, looks like they are moving according to plan.

[jump1]

Patience will pay. This is setting up nice.

NEW YORK, NY December 7, 2022, Nexteligent Holdings, Inc. (OTC:NXGT)— Nexteligent Holdings, Inc. announced today the appointment of Thomas Papini as an independent Director to fill the vacancy for the sixth seat on the Company’s Board of Directors. The appointment expands the Nexteligent Board from three to four independent Directors. Mr. Papini has over 35 years of experience as a finance executive at both leading corporations and startups, including National Health Promotion Associates, the American Broadcasting Company (ABC), and Make-A-Wish Foundation. He will support Nexteligent’s growth initiatives, including up listing to the OTCQX, which requires the formation of an independent audit committee. Additionally, Mr. Papini will support Nexteligent’s future acquisition process following its planned acquisition of IMS Experts, a national provider of Durable Medical Equipment that will join Nexteligent’s existing Revenue Cycle Management operations.

[jump1]

Hey Bones, I am always checking for updates for NXGT Because they don’t always announce.

Patience will pay.

NEW YORK, NY December 7, 2022, Nexteligent Holdings, Inc. (OTC:NXGT)— Nexteligent Holdings, Inc. announced today the appointment of Thomas Papini as an independent Director to fill the vacancy for the sixth seat on the Company’s Board of Directors. The appointment expands the Nexteligent Board from three to four independent Directors. Mr. Papini has over 35 years of experience as a finance executive at both leading corporations and startups, including National Health Promotion Associates, the American Broadcasting Company (ABC), and Make-A-Wish Foundation. He will support Nexteligent’s growth initiatives, including up listing to the OTCQX, which requires the formation of an independent audit committee. Additionally, Mr. Papini will support Nexteligent’s future acquisition process following its planned acquisition of IMS Experts, a national provider of Durable Medical Equipment that will join Nexteligent’s existing Revenue Cycle Management operations.

[BIOCHEMUP]

What the F is going on here lol. Nexteligent…

[FIREMEDIC0001]

Sounds promising

[seven77]

From the 10q filed on 11/13 the acquisition was made official . I can't wait to see the next financial report.

As of this Q2 2022 filing, Nexteligent has now finalized and signed its Asset Purchase Agreement for Innovative
Medical Solutions Experts (“IMS”), a national distributor of Durable Medical Equipment headquartered in Texas.
Under the terms of the Asset Purchase Agreement (“APA”), Nexteligent is paying (i) cash of $5,200,000 of which
$4,200,000 is paid at the closing of the transaction and the balance is being paid in the form of a promissory note
of two annual installments on the anniversary date of the APA of $500,000 each and bearing simple interest of 6%
per annum and (ii) 1,800,000 shares of Series C preferred stock which is non-voting and converts at a conversion
price equal to the 30-day average closing price of Nexteligent’s common stock prior to the date of the conversion
request. The current executives of IMS, Craig Welch and Parker Welch, will join as President and CEO and Director
of Operations, respectively, of Nexteligent’s new wholly owned subsidiary, to be named IMS Experts, Inc

[2times2]

Authorized Shares 100,000,000 11/11/2022
Outstanding Shares 73,937,469 11/11/2022
Restricted 36,406,813 11/11/2022
Unrestricted 37,530,656 11/11/2022

[urge2surge]

They should have as a fundamental basic of fiduciary disclosure. Why didn't they? Beyond the pale in their basic duties and responsibilities towards shareholders.

[EmptyBones]

Agree 100%

[seven77]

It would be nice if they could give more details on the planned acquisition. Did it go though? It looks like the target company is profitable. A PR on this could send the stock flying.
https://www.zoominfo.com/c/ims-experts-llc/411706329
"Additionally, the Board of Directors approved the acquisition of IMS Experts (IMS). IMS is a BOC accredited and licensed Medicare Durable Medical Equipment (DME) provider with over 700 in network private insurance companies, including Medicare and workers comp DME claims. Founded in 2003, the company works with hospitals, Physician clinics and directly with patients to provide a comprehensive complement of DME products."

[jump1]

It will happen, I think you and I have been here before the name change. I like it doing what it is doing. Building… I like the no pump thing. It is their MO, not a lot through the year. I think a doozy will drop soon. SS is the best even with 100 M AS Is the best for limit reporting stocks. Lowest.

This is one you get out of bed and flip computer on and NXGT is .10 plus for starters.

[EmptyBones]

SS no change.. Such a low SS. What a shame they don't communicate with shareholders.

[FIREMEDIC0001]

Looks like it's already dead

[EmptyBones]

Yep exactly...

[urge2surge]

Yeah stellar management needs to be reminded that an uplist involves an appreciating stock valuation of .25 minimum. Lmao. Wait until they score another " Winner" acquisition...lol.. Losers..

[EmptyBones]

NXGT is dying slowly..

[urge2surge]

Best scenario is that this acquisition makes them better suited for a RM target. I suspect whatever interests they previously had were absconded. Probably the uplist as well.
Either way the OTC is still under intentional market forces. They're not permitting anything to substantially run.
Go Joe Brandon.

[BIOCHEMUP]

Yeah after writing the post I started thinking about the price conversion again, you are right. Yeah, they are not cash heavy like all OTC’s so we’ll have to wait and see if this fits into a bigger plan with another complementary acquisition in the pipelines I guess.

[urge2surge]

The preferred have a time conversion so at the present time shares will remain the same. However, they are dillutive and the subsequent response by the markets indicate weakness. Furthermore, the lack of disclosures by corporate on the financial metrics, let alone a lack of official press releases, and zero investors conference to inform shareholders, is a huge vacuum. Not much anyone can do here aside from selling shares at an abysmal level. On a lot of levels, not much intentions or confidences towards a higher goal of uplist.
Just my take.

[BIOCHEMUP]

But there is no new issuance of common shares though, for the acquisition only preferred shares has been used.

IMS is a BOC accredited and licensed Medicare Durable Medical Equipment (DME) provider with over 700 in network private insurance companies, including Medicare and workers comp DME claims. Founded in 2003, the company works with hospitals, Physician clinics and directly with patients to provide a comprehensive complement of DME products.

There hasn’t been a new acquisition since November 2020 with PRMS. So as Thor said, although people were expecting much more thanks to the hype build up last year with CFAW on board. It is progress nonetheless. The network of 700 private insurance companies is great IMO. As long as the SS stays here in this range I see this as an accomplishment, maybe not as big as some have hoped.

[EmptyBones]

Yep it looks that way...

[urge2surge]

What a corporate board full of poop dujor... Outstanding delivery lmfao

[urge2surge]

The greatest non event reaction to their stellar acquisition. On a sub 100 million authorized stock. A real dog here..

[BIOCHEMUP]

All these OTC stocks are in the shitter since summer ‘21.

[urge2surge]

Over a quarter for the QB uplist. A lot of issues here no doubt. No contemporary press release on the acquisition, despite it was over a year, zero financial metric disclosures, zero active accretive or market value ascribed. Poops...

[EmptyBones]

Yes i think they need to get to .12 for a sustained period... 1 yr no news tells me they have problems imo..

[urge2surge]

Latest share updates have no additional shares added on the outstanding. No disclosures on acquisition metrics. Zero accretive valuation on purchase. All as if it never happened. No directional guidance or corporate updates. Lol..

[urge2surge]

Uplisting usually involves an increase in stock price no? Lagging share update to. Interesting...

[urge2surge]

You wrote "complete". Save the spin for those that matter. Lol...